At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing.  Our small molecule platform accelerates drug development across a broad range of disease types. 

Biotechnology

Skyhawk Therapeutics

Bill Haney

Joseph Duffy

Botao Liu

Amparo Garcia Lopez

Olesia Buiakova

Mischa K.

Laurent Brault

John McKeague

Cassidy Flynn-Rozanski

Loren Berry

Clinton Musil

Terrance Connolly

The Leadership Team at Skyhawk Therapeutics is responsible for guiding the company's strategic vision and operational direction. Comprising executives with expertise in market development, legal affairs, chemistry, and overall management, this team fosters innovation, drives drug development initiatives, and ensures alignment across all functions to enhance the efficacy of small molecule therapies for RNA splicing disorders.

Leadership Team

Scientific Research and Development

Advisory Team

Leadership Team

About

Team members

Other teams at Skyhawk Therapeutics

Scientific Research and Development

Advisory Team